International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
The Role of Gut Microbiota Dysbiosis on the Pathogenesis of Cardiovascular Diseases- A Review
| Author(s) | Dr. Aditi Munmun Sengupta, Sabarni Mandal, Mrinal Kanti Das, Jayanta Datta |
|---|---|
| Country | India |
| Abstract | The regulation of human physiology is greatly influenced by interactions between the intestinal microbiota and the host. Gut dysbiosis, or harmful changes to the gut microbiota, has been associated with the onset and progression of several illnesses, including cardiovascular disease (CVD). In the entire world, cardiovascular disease (CVD) is the main cause of death. The regulation of the host's metabolism and energy-harvesting mechanism is largely dependent on the gut bacteria. Changes in the gut microbiota derived metabolites and variations in the microbial flora have been demonstrated to significantly correlate with a number of CVD risk factors. Below is a detailed discussion of the function of gut microbial dysbiosis in dyslipidemia, atherosclerosis and coronary artery disease (CAD), hypertension, chronic heart failure (CHF), even myocardial infarction, and related treatment implications. However, there are even more, such as dietary changes, probiotics, and prebiotics, which may one day be utilised to process the microbial population and change its functional output for the benefit of the host. With a focus on the intricate interactions between microbiota, their metabolites, and cardiovascular disease (CVD), this review will cover the roles of gut microbiota in healthy physiology, their associations with disease settings, and the possibility of modulating gut microbiota as novel therapeutic targets. |
| Keywords | Microbiota, dysbiosis, cardiovascular diseases, pre and probiotics, therapeutics |
| Field | Biology > Medical / Physiology |
| Published In | Volume 7, Issue 5, September-October 2025 |
| Published On | 2025-10-02 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i05.50431 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals